| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 7,214,000 | 6,662,000 | 6,307,000 | 6,521,000 | | Cost of Revenue | 6,752,000 | 6,192,000 | 6,054,000 | 6,503,000 | | | Gross Profit | 462,000 | 470,000 | 253,000 | 18,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 224,000 | 194,000 | 224,000 | 216,000 | | Non Recurring | 560,000 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (322,000) | 276,000 | 29,000 | (198,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 8,000 | 2,000 | (14,000) | | Earnings Before Interest And Taxes | (319,000) | 284,000 | 31,000 | (212,000) | | Interest Expense | 85,000 | 88,000 | 74,000 | 63,000 | | Income Before Tax | (404,000) | 196,000 | (43,000) | (275,000) | | Income Tax Expense | 52,000 | 70,000 | 47,000 | (155,000) | | Minority Interest | 1,000 | 1,000 |
-
| 2,000 | | | | Net Income From Continuing Ops | (455,000) | 127,000 | (90,000) | (118,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 7,000 | (14,000) | 6,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (455,000) | 134,000 | (104,000) | (112,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($455,000) | $134,000 | ($104,000) | ($112,000) |
|
1.52% Nasdaq 
Income Statement
